Concepedia

Emily A. King

EA

4

Publications

856

Citations

4

H-Index

2017

Active since

Affiliations

AbbVie (United States)(Current)

Emily A. King is an author at AbbVie (United States) specializing in clinical trials, epidemiology, and drug repositioning.

ORCID

Top concepts

Publications per year

2017–2021

4

Publications

4

Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval

Emily A. King, J. Wade Davis, Jacob F. Degner · PLoS Genetics · 2019 · 658 citations · Full text

, , +22

An omnibus test for differential distribution analysis of microbiome sequencing data

Jun Chen, Emily A. King, Rebecca A. Deek et al. · Bioinformatics · 2017 · 109 citations · Full text

Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval

Emily A. King, J. Wade Davis, Jacob F. Degner · 2019 · 76 citations · Full text

, , +30

Estimating colocalization probability from limited summary statistics

Emily A. King, Fengjiao Dunbar, J. Wade Davis et al. · BMC Bioinformatics · 2021 · 13 citations · Full text

Rows per page

1–4 of 4